EMAIL THIS PAGE TO A FRIEND

PloS one

Inhibition of glycogen synthase kinase-3β attenuates glucocorticoid-induced suppression of myogenic differentiation in vitro.


PMID 25127359

Abstract

Glucocorticoids are the only therapy that has been demonstrated to alter the progress of Duchenne muscular dystrophy (DMD), the most common muscular dystrophy in children. However, glucocorticoids disturb skeletal muscle metabolism and hamper myogenesis and muscle regeneration. The mechanisms involved in the glucocorticoid-mediated suppression of myogenic differentiation are not fully understood. Glycogen synthase kinase-3β (GSK-3β) is considered to play a central role as a negative regulator in myogenic differentiation. Here, we showed that glucocorticoid treatment during the first 48 h in differentiation medium decreased the level of phosphorylated Ser9-GSK-3β, an inactive form of GSK-3β, suggesting that glucocorticoids affect GSK-3β activity. We then investigated whether GSK-3β inhibition could regulate glucocorticoid-mediated suppression of myogenic differentiation in vitro. Two methods were employed to inhibit GSK-3β: pharmacological inhibition with LiCl and GSK-3β gene knockdown. We found that both methods resulted in enhanced myotube formation and increased levels of muscle regulatory factors and muscle-specific protein expression. Importantly, GSK-3β inhibition attenuated glucocorticoid-induced suppression of myogenic differentiation. Collectively, these data suggest the involvement of GSK-3β in the glucocorticoid-mediated impairment of myogenic differentiation. Therefore, the inhibition of GSK-3β may be a strategy for preventing glucocorticoid-induced muscle degeneration.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB4300397
Anti-MYOD1 (Ab-200) antibody produced in rabbit, affinity isolated antibody
SAB2105139
Anti-MYOD1 antibody produced in rabbit, affinity isolated antibody
SAB1410813
Anti-MYOD1 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
HPA038093
Anti-MYOG antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1410814
Anti-MYOG antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
M6190 Monoclonal Anti-MYOD1 antibody produced in mouse, clone 5.2F, purified immunoglobulin, buffered aqueous solution
WH0004654M1
Monoclonal Anti-MYOD1 antibody produced in mouse, clone 1A7, purified immunoglobulin, buffered aqueous solution
SAB5300415
Monoclonal Anti-MYOD1 antibody produced in mouse, clone 1C8, ascites fluid
WH0004656M1
Monoclonal Anti-MYOG antibody produced in mouse, clone 2B7, purified immunoglobulin, buffered aqueous solution
SAB1404106
Monoclonal Anti-MYOG antibody produced in mouse, clone 2E7, purified immunoglobulin, buffered aqueous solution
SAB1409339
Monoclonal Anti-MYOG antibody produced in mouse, clone 3E3, purified immunoglobulin, buffered aqueous solution
M5815 Monoclonal Anti-Myogenin antibody produced in mouse, clone F12B, purified immunoglobulin, buffered aqueous solution